J3386
HCPCSEtuvetidigene autotemecel
Official HCPCS Level II long descriptor
Injection, etuvetidigene autotemcel, per treatment
HCPCS Level II code J3386 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Etuvetidigene autotemecel
Added to HCPCS: 2026-07-01
Nearby codes in J3
- J3360Diazepam injection
- J3373Inj, vancomycin hcl, 10 mg
- J3374Inj, vancomycin (mylan) 10mg
- J3375Inj, vanco (tyzavan) 10mg
- J3376Inj vancomycin (hikma) 10mg
- J3379Inj, valproate sod, 5 mg
- J3380Inj vedolizumab iv 1 mg
- J3385Velaglucerase alfa
- J3387Inj elivaldogene autotemecel
- J3389Topi adm prad zami per treat
- J3391Inj, atidarsagene autotemcel
- J3392Inj, exagamglogene autotem
- J3393Inj, betibeglogene autotemce
- J3394Inj, lovotibeglogene autotem
- J3396Verteporfin injection
- J3397Inj., vestronidase alfa-vjbk
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.